A Public Resource Compiled by the

Africa: Crops / Food

Print Friendly, PDF & Email
Africa Non-Flag

Mostly Prohibited

Regulatory pathway for gene edited crops has not been implemented in many countries, with the exception of Nigeria and Kenya.

Agricultural gene editing remains a hope rather than a surety. After years of hesitancy over the role of genetically engineered crops (both genetically modified and gene edited) across the continent, in recent years many nations have committed more funding to research and development. Although a few transgenic genetically modified (GM) crops are commercially grown, the process for approvals remains challenging in every country. Gene editing was aspirationally endorsed under the African Union Agenda 2063. So far, two countries —Nigeria and Kenya—have implemented guidelines for a case-by-case review of genome-edited crops, but no African country has yet approved one. Some gene-edited crops are in trials.

Almost all the research on genetically engineered crops in Africa is spearheaded by public scientists. Each country manages its own policies and for the most part is pursuing an independent path in regulating GM crops and gene editing.

Fgeed-04-876697-g001

Major staple food crops addressed in this article and  the countries where genome-edited trials are underway (Karembu, 2021)

Seven African countries —  Nigeria (maize/corn, cowpea, cotton, soybean), South Africa (cotton; soybean, maize/corn), Ethiopia (cotton), Kenya (cotton), Malawi (cotton), Sudan (cotton) and Eswatini [formerly Swaziland] (cotton) — have commercialized four GM crops focusing on insect resistance or herbicide tolerance. (Burkina Faso (cotton) and Egypt (cotton) had grown GM transgenic crops commercially but approvals were suspended.) Eleven African countries have 34 additional GM crops in trials at various levels of advancement.

Regulatory documents for commercial release of GM crops and status of legislation on gene edited plants

Here is the regulatory status for the commercialization of GM and gene edited crops in these 11 African countries:

Screen shot 2022-08-31 at 10.54.14 am

 

It is anticipated that the approval process for gene-edited crops, at least initially, will fall under established transgenic GM regulations in most countries even as most others are setting up separate and distinct gene editing oversight. There are a few promising exceptions. So far, two countries, Nigeria and Kenya, have implemented regulations for a case-by-case review of genome-edited crops.

Nigeria, in December 2020 approved guidelines on crop gene editing issued by the National Biosafety Management Agency (NBMA), becoming the first African nation to issue science-based gene editing guidelines. The guidelines break from GM regulations, stating that when gene editing of a product does not lead to a new combination of genetic material (as happens with GM transgenics), a new case-by-case regulatory provision leading to issuance of Biosafety Approval (Clearance) would apply. If however the gene editing of the product leads to a new combination, the classification of ‘’GMO’’ would be given, and the Act and the National Biosafety Regulations 2017 would apply.

Kenya’s National Biosafety Authority published science-based guidelines in February 2022 to facilitate the development of gene-edited research and plant and animal products. Both research and products will be reviewed on a case-by-case basis. The guidelines provide for early consultation to determine the regulatory pathway to be adopted in view of potential outcomes of genome editing procedures. The guidelines do not extend to detailing how risk assessment and risk management of genome-edited products will be conducted, which means that field trials and commercialization remains far off. The guidelines are applied to genome edited plants, animals and microorganisms.

Kenya already has multiple agricultural gene editing research projects in the planning stages involving sorghum, maize, bananas, pigs and cattle. They include building resistance in the sorghum plant against the parasitic striga weed, controlling maize lethal necrosis disease, disease-resistant varieties of banana, drought-tolerance in maize and developing vaccines against African Swine Fever Virus (ASFV) and East Coast fever (ECF), two dangerous diseases affecting pigs and cattle, respectively.

South Africa, an early leader in the introduction of GM crops to Africa, has not yet embraced a path to gene editing approvals and commercialization. In October 2021 the government classified genome-edited plants as genetically modified crops based on its interpretation of the definition of 25-year-old legislation rather than on recent science-based risk analysis, suggesting a challenging path to widespread commercialization.

Products/Research

  • Weed resistant sorghum, 2022:  Kenyan scientists have developed a sorghum resistant to striga, a parasitic weed that attaches itself to roots of host crops and sucks out nutrients and kills the host crop.
  • Pest resistant cowpea, 2021: After the successful introduction of GM Cowpea variation SAMPEA 20-T, the Ghanese government began commercialization of the same crop on the Ghanese market.
  • Cassava resistant to brown streak disease, 2020: Uganda scientists are attempting to improve the tolerance of cassava against Cassava Brown Streak Virus using CRISPR.
  • Climate smart banana, 2019:  International Institute of Tropical Agriculture (IITA) in Kenya is developing bananas resistant to banana bacterial wilt, fusarium silt and banana streak virus, a process expected to take until at least 2023.
  • Pest resistant cowpea, 2019: In coordination with the African Agricultural Technology Foundation, Nigeria begins the commercialisation of transgenic Cowpea variation SAMPEA 20-T, which is resistant to the pest Maruca Vitrata, responsible for 80% crop loss.
  • Cassava with reduced cyanogen production, 2018: The Innovative Genomics Institute is attempting to use CRISPR to reduce the amount of toxic cyanogenic glycosides in cassava, thereby reducing the incidence rate of the toxico-neurological disease konzo, which can help increase crop yield in East, Central and West Africa
  • Disease resistant cacao, 2018: Pennsylvania State University researchers used CRISPR to begin developing cacao with properties that will help African farmers produce more, including resistance to Cocoa Swollen Shoot Virus (CSSV), a common and devastating cacao disease in West Africa.

Regulatory Timeline

2022: Kenya’s National Biosafety Authority published science-based guidelines. Both gene-editing research and gene-edited products will be reviewed on a case-by-case basis.

2021: The government of South Africa classified genome-edited plants as genetically modified crops based on its interpretation of the definition of 25-year-old legislation rather than on recent science-based risk analysis.

2021: Ghana government resumes approval of countries first GMO crop, the insect resistant cowpea.

2021: Government of Nigeria approves National Biosafety Guideline on Gene Editing. Through the NBMA the Nigerian government authorized the guidelines on gene editing.

2019: Senegal drafts revised Biosafety Law that could expedite the approval process for certain genetically engineered products, but it is unclear how long the evaluation and approval process will take until the revised law is adopted. Whether the government of Senegal describes genetically engineered products as both GM and/or gene-edited is unclear.

2019: African Union considers harmonizing biosafety regulations to foster development of biosafety regulatory systems and tools and improve access and utilization by AU member-states.

2016: South Africa’s Department of Science and Technology commissions an expert report on the regulatory implications of NBTs, which recognized that NBTs may be more precise than transgenics and may thus require a lower/different level of regulatory scrutiny. No regulatory amendment has yet been formally proposed.

2016: The Economic Community of West African States (ECOWAS) develops a draft regional biosafety law, but it is still undergoing evaluation and approval.

2015: Nigeria signs Biosafety Act regulating the handling and use of genetically engineered crops, requiring mandatory labeling of products or ingredients.

2013: African Science Academies in Ethiopia issues statement supporting biotechnology, saying “biotechnology-enhanced tools and products can play a significant and positive role in meeting Africa’s dire need and persistent challenge to break the seemingly perpetual cycle of hunger, malnutrition, and underdevelopment.”

2009: Kenya Biosafety Act 2009, which includes clauses on labelling GMOs, passes.

2009: Senegal Biosafety Law, which outlines the approval process for genetically engineered crops, is adopted.

2008: South Africa’s Consumer Protection Act No. 68 of 2008 requires GMO labels on food.

2003: Nigeria and Ghana ratify Cartagena Protocol, which oversees the transport and use of organisms modified by biotechnology.

2001: Nigeria establishes National Biotechnology Development Agency (NABDA) to promote, commercialize and regulate biotechnology products.

1998: South Africa’s National Environmental Management Act No. 107, which strictly regulates GMOs with “foreign” DNA (transgenes), passes.

1997: South Africa’s Genetically Modified Organisms Act No. 15 defines a GMO as “an organism the genes or genetic material of which has been modified in a way that does not occur naturally through mating or natural recombination or both” and requires risk and environmental impact assessments.

NGO Reaction

NGOs, many with connections with European advocacy groups, have been very active throughout Africa in discouraging the adoption of GMOs, and it is expected they will redirect their opposition to gene-edited crops as research progresses and various countries consider regulations.

The African Center for Biodiversity (ACB) and the Alliance for Food Sovereignty in Africa (AFSA) are among the most vocal opponents of biotechnology on the continent. ACB has proposed indefinite bans on gene editing. In 2019, AFSA has called on governments to “abandon all activities supporting the introduction of GMO seeds or seeds derived from new biotechnologies” including gene editing.

South African lobby group, Biowatch, has argued that genetic engineering is “controversial” with “dubious economic advantages”. Biowatch is funded by multiple anti-GMO organizations, most based in Europe.

In Ghana, scientists urged anti-GMO groups to accept gene editing, especially with climate change threatening to impact cacao production, but multiple farmer and agriculture organizations, many linked to global and European anti-GMO environmental groups, have supported the government’s decision in 2020 to prohibit GMOs.

Various anti-capitalist advocacy groups in Nigeria, led by the Health of Mother Earth Foundation (HOMEF), which has links to global anti-biotechnology groups including Canada’s ETC Group and the London and Boulder, CO-based Global Greengrants Fund, claims that embracing biotechnology will lead to western control of the African food economy.

Additional Resources

Updated: 05/24/2023

Click on a country (eg. Brazil, US) or region (eg. European Union) below to find which agriculture products and processes are approved or in development and their regulatory status. The regulations on genetically engineered crops and animals are emerging out of the regulatory landscape developed for transgenic GMOs.

World single states political map

European Union

European Union

Switzerland

Switzerland

Brazil

New Zealand

New Zealand

United States

United States

Australia

Australia

Canada

China

United Kingdom

United Kingdom

Israel

Argentina

Argentina

Japan

Mexico

Russia

Chile

Uruguay

Paraguay

India

Africa

Ukraine

Southeast Asia

Southeast Asia

Central America

Central America

Colombia

Norway

Ecuador

Cuba

Argentina

Australia

Central America

European Union

New Zealand

Southeast Asia

United Kingdom

United States

Agriculture Gene Editing Index
Compare Regulatory Restrictions Country-to-Country

Gene editing regulations worldwide are evolving. The Gene Editing Index ratings below represent the current status of gene editing regulations and will be updated as new regulations are passed.

Colors and ratings guide
 

Regulation StatusRating
Determined: No Unique Regulations*10
Lightly Regulated8
Proposed: No Unique Regulations†6
Ongoing Research, Regulations In Development5
Highly Regulated4
Mostly Prohibited2
Limited Research, No Clear Regulations1
Prohibited0
Lightly Regulated: Some or all types of gene editing are regulated more strictly than conventional agriculture, but not as strictly as transgenic GMOs.
*Determined: No Unique Regulations: Gene-edited crops that do not incorporate DNA from another species are regulated as conventional plants with no additional restrictions.

†Proposed: No Unique Regulations: Decrees under consideration for gene-edited crops that do not incorporate DNA from another species would no require unique regulations beyond current what is imposed on conventional breeding.

Crops/Food:
Gene editing of plants and food products. Research and development has mostly focused on disease resistance, drought resistance, and increasing yield, but more recent advances have produced low trans-fat oils and high-fiber grains.
Animals:
Gene editing of animals, not including animal research for human drugs and therapies. Fewer gene edited animals have been developed than gene edited crops, but scientists have developed hornless and heat-tolerant cattle and fast-growing tilapia may soon be the first gene edited animal to be consumed.

Rating by Country / Region
Click each column header and arrow to sort the countries / regions

Swipe right/left if all columns aren't visible

Country / RegionFood / CropsAnimalsAg Rating
Ecuador101010
Norway666
Africa555
Japan888
Brazil101010
Canada888
Russia555
Argentina101010
Israel1057.5
Australia888
Switzerland555
China555
US1047
Chile1015.5
New Zealand444
Ukraine111
Central America666
Paraguay101010
Uruguay666
India666
UK222
Mexico111
EU222
Colombia1015.5

Global gene editing regulatory landscape

The regulations on genetically engineered crops and animals are emerging out of the regulatory landscape developed for transgenic GMOs. Regulations across 34 countries where transgenic or gene edited crops and animals are commercially allowed (as of 12/19) are guided in part by two factors:
 
 
Whether the country has ratified the international agreement that took effect in 2003 that aims to ensure the safe handling, transport and use of living modified organisms (LMOs) resulting from biotechnology that may impact biological diversity, also taking into account potential risks to human health. It entered into force for those nations that signed it in 2003. It applies the ‘precautionary approach as contained in the Rio Declaration on Environment and Development. The US, Canada, Australia and Chile and the Russian Federation have not signed the treaty.
 
 
Whether regulations are based on the genetic process used to create the trait (conventional, mutagenesis, transgenesis, gene editing, etc.) or the final product.Transgenic crops and animals (aka GMOs) are product regulated in many countries including the US and Canada, while the EU, India, China and others regulate based on how the product is made. There is almost an equal number of countries with product- and process-based regulations. It’s not clear how much this distinction matters. It’s somewhat true that countries with product-based regulation have more crops approved and the approval process is more streamlined, but there are contradictions. For example, Brazil and Argentina have emerged as GMO super powers using different regulatory concepts, while there is no GMO commercial cultivation in Japan, North Korea, and the Russian Federation, which employ product-based regulations. How this will effect gene editing regulations is also unclear. For example, Japan, which has no commercialized GMOs, is emerging as a leader in the introduction of gene edited crops.
Agricultural Landscape
Share via

Gene editing is a set of techniques that can be used to precisely modify the DNA of almost any organism. It is being used for applications in human health, gene drives and agriculture. There are numerous gene-editing tools besides CRISPR-Cas 9, which gets most of the attention because it is a comparatively easy tool to use.

Gene editing does not usually involve transgenics – moving ‘foreign’ genes between species. It also refers to a specific technique in contrast to the general term GMO, which is scientifically ambiguous, as genetic modification is a process not a product. Most gene editing involves creating new products by deleting very small segments of DNA (sometimes in agriculture called Site-Directed Nuclease 1 or SDN-1 techniques), which can silence a gene or change a gene’s activity. Countries are evaluating whether or not to regulate this type of gene editing, since it is so similar to natural mutations. The GLP’s Gene Editing Index ratings reflect the regulatory status of SDN-1 techniques, which are the most liberally regulated and will generate most products in the near term.

To develop different products, gene editing can change larger segments of DNA or add DNA from other species (a form of transgenics sometimes in agriculture called SDN-2 or SDN-3 techniques). While many countries are not regulating or lightly regulating SDN-1 techniques, most are moving toward tightly regulating or even restricting SDN-2 and SDN-3.

For more background on the various gene editing SDN techniques, read background articles here and here.